Taiwan Semiconductor
TSM
Adobe
ADBE
Apple
AAPL
4
Cisco
CSCO
5
Alibaba
BABA
US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.7281
- +0.0002+0.03%
Trading Apr 30 12:58 ET
212.62MMarket Cap-3.64P/E (TTM)
0.7295High0.6906Low1.21MVolume0.7200Open0.7279Pre Close853.34KTurnover0.42%Turnover RatioLossP/E (Static)292.01MShares2.060052wk High7.21P/B209.24MFloat Cap0.515052wk Low--Dividend TTM287.37MShs Float778.1999Historical High--Div YieldTTM5.34%Amplitude0.1700Historical Low0.7070Avg Price1Lot Size
About Ocugen Company
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Company Profile
SymbolOCGN
Company NameOcugen
Listing DateDec 3, 2014
Issue Price11.00
Founded2013
CEODr. Shankar Musunuri, M.B.A.,PhD
MarketNASDAQ
Employees95
Fiscal Year Ends12-31
Address11 Great Valley Parkway
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-484-328-4701
Websitehttp://www.ocugen.com
Company Executives
- Name
- Position
- Salary
- Dr. Shankar Musunuri, M.B.A.,PhD
- Chairman of the Board and Chief Executive Officer
- 1.94M
- Ramesh Ramachandran
- Principal Financial Officer and Chief Accounting Officer
- --
- Arun Upadhyay, PhD
- Chief Scientific Officer and Head, Research and Development
- 870.87K
- Dr. Huma Qamar, M.D.,PhD
- Chief Medical Officer
- 1.73M
- Blaise A. Coleman
- Director
- --
- Dr. Satish Chandran, PhD
- Director
- --
- Kirsten Castillo, M.B.A.
- Independent Director
- 114.76K
- Dr. Uday B. Kompella, PhD
- Independent Director
- 101.64K
- Dr. Prabhavathi Fernandes, PhD
- Lead Independent Director
- 132.26K
- Dr. Marna C. Whittington, PhD
- Independent Director
- 107.26K
- Dr. Junge John Zhang, PhD
- Independent Director
- 86.64K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025